Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054873 · ClinicalTrials.gov registry record · Phase 2
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
A Phase 2 study, sponsored by Chiron Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00054873: Completed Phase 2 study, sponsored by Chiron Corporation.
NCT00054873 is a Phase 2 study that has completed, run by Chiron Corporation. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00054873, a Phase 2 study, has completed, sponsored by Chiron Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
Interventions
- DRUG 5-fluorouracil
- DRUG tezacitabine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-11 |
| Est. Completion | 2004-12 |
| Phase | Phase 2 |
What the finished NCT00054873 record still lists
NCT00054873 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which 5-fluorouracil is the first listed.
NCT00054873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00054873 about?
NCT00054873 is a clinical study titled "Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer". The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
What is the current status of trial NCT00054873?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-11. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00054873?
The interventions under investigation include: 5-fluorouracil (DRUG), tezacitabine (DRUG).
Who is sponsoring clinical trial NCT00054873?
This trial is sponsored by Chiron Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia